Clinical Trial Update: Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of conivaptan for reducing cerebral edema in intracerebral hemorrhage has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Edema
• Cerebral Hemorrhage
• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• Conivaptan (conivaptan)

Snippet

Sponsor: Jesse Corry | Conditions: Cerebral Hemorrhage, Cerebral Edema | Phase 1 | Status: COMPLETED | Results posted: 2020-04-17